Advocacy regarding changes to policies or programs related to the Expensive Drugs for Rare Diseases (EDRD) program, including pharmacy participation, reimbursement, dispensing, distribution, and related program requirements for rare disease therapies
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|